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 Introduction 
 As a designed manufacturing technology, solid free-form fabri-
cation (SFF) or rapid prototyping (RP) has drastically improved 
our ability to fabricate objects with customized designs, com-
plex geometries, precise dimensions, and controllable archi-
tecture. In fact, RP is a group of techniques that can generate 
a physical model directly from computer-aided design (CAD) 
data in a layer-by-layer manner, where each layer is the shape 
of the cross-section of the model at a specifi c level. 1 In apply-
ing RP techniques in biomedical engineering, the data used to 
design and fabricate objects are usually based on data from 
CADs, computer-based medical imaging technologies such as 
magnetic resonance imaging (MRI) and computer tomography 
(CT), or other computer-based technologies. 2 Computer-based 
data are converted to an STL fi le format (which is a standard 
format for RP techniques), STL being derived from “stereo-
lithography,” the oldest RP technology. The computer-generated 
two-dimensional layers are then assembled, and a concrete 
model is created, starting from the bottom and proceeding 
upward. In production, each layer is bonded to the previous 
layer, producing a solid object based on the design. 
 Based on their working principles, RP techniques can be 
divided into several categories: laser polymerization-based 
techniques, such as stereolithography apparatus and two-photon 
polymerization; nozzle deposition-based techniques, such as 
fused deposition modeling and three-dimensional (3D) plotting; 
and powder-based techniques, such as 3D printing (3DP) and 
selective laser sintering (SLS). 3,4 Generally, each technique 
is suitable for a specifi c material (or group of materials) or a 
specifi c form of the material and has its own advantages and 
disadvantages. 
 Two decades ago, tissue engineering emerged as a prom-
ising alternative to using autografts, the gold standard in cur-
rent surgery, and allografts for tissue repair and regeneration. 
There are several strategies in tissue engineering, including 
cell-based tissue engineering, factor-based tissue engineering 
and scaffold-based engineering. For cell-based tissue engi-
neering, autologous or allogeneic cells are fi rst isolated and 
then injected in single cell suspensions at the targeted sites of 
patients, or they can be manipulated by cell assembly into mul-
ticellular spheroids or cell sheets for transplantation in patients. 
Factor-based tissue engineering is conducted by the injection 
of biomolecules (normally in a carrier), such as growth and 
differentiation factors, or genes to targeted locations in patients. 
For scaffold-based tissue engineering, cells and/or biomolecules 
are encapsulated within the matrices or seeded onto the surface 
of three-dimensional (3D) scaffolds for tissue regeneration. 4
The scaffolds serve as extracellular matrix to direct cell adhe-
sion, proliferation and differentiation and thus promote new 
tissue formation. With the emergence and development of tissue 
engineering, various biomaterials and RP techniques are being 
investigated for fabricating porous scaffolds with controlled 
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architectures (pore size, shape, interconnectivity, porosity) and 
properties (biological, mechanical), targeting the regeneration 
of different tissues. 5 – 7 
 SLS employs a laser beam, usually a CO 2 laser, to selec-
tively sinter thin layers of powdered polymers or polymer-based 
composites, forming solid 3D objects with macro- and micro-
scale features. SLS has several advantages in forming designed 
objects, including high part accuracy, material versatility, and 
no need for part support during manufacture because the mate-
rial not fused together by the heat generated by the laser beam 
provides a good support for the object being sintered. It has thus 
been used for constructing models for surgical planning and for 
medical device prototyping. In addition, SLS is highly capable 
of producing objects with irregular shapes, including struc-
tures containing channels and overhanging features. 1 Therefore, 
SLS is a very attractive RP technique for the fabrication of 
tissue engineered scaffolds with controlled pore structure, pore 
size, and customized scaffold architecture. In this article, the 
working principle of SLS and modifi cations of SLS machines 
are reviewed. Materials used in SLS and optimization of SLS 
parameters for fabricating good-quality objects are highlighted. 
Biomedical applications of SLS, especially in tissue engineer-
ing and drug/biomolecule delivery, are presented and discussed. 
 Selective laser sintering 
 SLS process and modifi cations of commercial SLS 
machines 
 SLS was developed and patented by Deckard and Beaman in 
the mid-1980s. It was commercialized in 1987 by DTM Cor-
poration, which was acquired by 3D Systems in 2011. Like 
most RP techniques, SLS is an additive fabrication process 
that allows the fabrication of objects from CAD fi les. The 
architecture (external and internal of structures) of objects can 
be designed using professional 3D-drawing computer soft-
ware, described by mathematical equations, 
or derived from data from imaging techniques 
such as MRI and CT ( Figure 1 a). The CAD fi le 
with information on geometry and dimensions 
of an object is converted into an STL fi le and 
input into an SLS machine. The machine then 
uses a fi ne-powder material to fabricate the 
3D object according to the designed model 
( Figure 1b–d ). During SLS, the powder material 
is heated up by a laser beam such that the surface 
tension of individual particles in the powder is 
overcome and the selectively sintered powder 
fuses together, solidifying a thin layer and then 
building a solid 3D object layer-by-layer. 
 Before the powder material is selectively 
sintered, the entire part bed (the area that con-
tains both the powder being sintered and the 
sintered part) of the machine is heated to just 
below the melting temperature of the mate-
rial (or near the glass transition temperature 
of amorphous polymers) in order to minimize 
thermal distortion and facilitate fusion of the sintered layer. 
The laser beam then scans over the cross-section on the pow-
der surface according to the cross-sectional profi les from the 
slice data, heating up the powder and causing particles to fuse 
together to form a solid layer. After one layer is fi nished, the 
part bed is lowered, and one of the powder tanks, which is 
fi lled with the powdered raw material, is raised. A new layer 
of powder is then spread by a roller, and the selective sintering 
process is repeated. The powder that is not scanned by the laser 
beam remains in place to serve as the support to the next layer 
of powder, then is removed and recycled once fabrication of 
the object is completed. 
 In a commercial SLS machine, an SLS process typically 
requires a powder supply of at least one-third of the pow-
der tank volume. Therefore, an unmodifi ed commercial SLS 
machine is not material-effi cient for producing objects with 
small dimensions and small features or for building tissue engi-
neering scaffolds using expensive materials. In our research, in 
order to reduce the consumption of biopolymer or biocompos-
ite powders for constructing tissue engineering scaffolds via 
SLS, modifi cations were made to a commercial SLS machine 
(Sinterstation 2000). 8 A miniature sintering platform was 
designed, fabricated, and installed in the build cylinder of 
Sinterstation 2000 ( Figure 2 c). The miniature platform con-
sisted of a miniature sintering platform ( Figure 2d ) and two 
powder tanks similar to the commercial machine but with much 
smaller dimensions (the size of powder tanks in a commercial 
Sinterstation 2000 SLS system is 325 × 250 × 370 mm 3 , and 
the size of miniature power tanks is 60 × 60 × 75 mm 3 ). After the 
modifi cations, only small amounts of powder were needed to 
fi ll the miniature powder tank. Similarly, a compact adaptation 
device for a Sinterstation 2500 machine was developed, which 
permitted the transfer of the motion of the part bed of the SLS 
machine onto the part bed of the compact device. 9 
  
 Figure 1.  The selective laser sintering (SLS) fabrication process. (a) Model design either 
using computer data from medical imaging or through computer software for 3D drawing 
(top: Trimetric view of a CAD design model of a tissue engineering scaffold with a strut 
size of 1 mm and pore size of 2 mm; bottom: A dragon model generated by a 3D scanner). 
(b) Fine powdered materials for SLS (left: Duraform powder; right: scanning electron 
microscopic image of Duraform powder). (c) Schematic diagram of the SLS process. (d) 3D 
objects formed by SLS using Duraform powder (top: sintered tissue engineering scaffold; 
bottom: sintered dragon). 
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 Apart from conventional SLS in which polymeric powders 
absorb infrared laser radiation ( λ = 10.6  μ m), resulting in volu-
metric absorption by the whole polymeric particle, near-infrared 
laser radiation ( λ = 0.97  μ m) can also be used to melt the surface 
of polymer particles. 10 Surface selective laser sintering (SSLS) 
thus makes it possible to melt the surface layer rather than 
the whole polymer microparticle and sinter the particles into 
3D objects. SSLS is suitable for sintering thermally unstable 
polymers (e.g., poly(lactic-co-glycolic acid) [PLGA]) and for 
fabricating scaffolds with delicate biomolecules incorporated 
in them. 11 
 Materials for SLS in biomedical engineering 
 Many materials, from polymers to metals to ceramics, can 
be processed by SLS for general engineering or biomedical 
applications. In theory, any material that can be processed into 
powder and can be sintered with heat may be used in SLS. In 
practice, seven types of materials, including wax, polycarbonate, 
nylon (standard nylon, fi ne nylon, fi ne nylon medical grade, 
and nylon composite) and acrylic, which are all commercially 
available, are often used. 12 Normally, CO 2 lasers with a wave-
length of 10.6  μ m are used for sintering polymers or mate-
rials with low melting temperatures. Nd:YAG lasers with a 
wavelength of 1.06  μ m can outperform CO 2 lasers for metallic 
and ceramic materials, which absorb much better at short wave-
lengths. 13 Pure Ti, Ti-6Al-4V, and NiTi alloy (Nitinol) were 
successfully sintered into 3D scaffolds using Nd:YAG lasers. 14 , 15 
Bioceramics such as hydroxyapatite (HA) could also be sintered 
to form customized implants for bone tissue repair. 16 , 17 The type 
of laser can affect the properties (mechanical 
properties, density, surface texture) of sintered 
objects. 
 Powdered materials for SLS should have 
appropriate particle sizes and have good 
fl owability for spreading on the part bed of 
the SLS machine. Materials with particle sizes 
of 10–150  μ m and with a spherical shape are 
preferred. 18 The polymer particle size was 
found to have signifi cant effects on scaffold 
properties. 19 Commercial SLS powder materials 
can be used directly or mixed with materials 
such as carbon black to form composite powders 
for SLS. For fabricating composite scaffolds 
for bone tissue repair, bioceramics such as 
HA have been dry-blended with a polymer and 
then made into a composite in an extruder. 20 
The extruded composite was subsequently 
pelletized and powdered for SLS. Using dry-
blended bioceramic-polymer mixtures directly 
for SLS was also attempted. 21 Another strategy 
was to fabricate polymer microspheres or com-
posite microspheres and use the microspheres 
for 3D scaffold fabrication. 8 As shown in 
 Figure 2a , calcium phosphate (Ca-P) nanopar-
ticles with sizes in the range of 10–30 nm were 
fi rst synthesized. Nanocomposite microspheres consisting of 
Ca-P nanoparticles and biodegradable poly(hydroxybutyrate-co-
hydroxyvalerate) (PHBV) polymer matrix, as shown in  Figure 2b , 
were then made using the solid-in-oil-in-water (S/O/W) 
emulsion-solvent evaporation technique. The nanocomposite 
microspheres were fi nally sintered into a scaffold in the shape of 
the proximal end of a human femur using a model reconstructed 
from CT images ( Figure 2e–f ). 
 SLS parameters and their optimization 
 In SLS, several parameters, including laser power, scan spacing, 
layer thickness, part bed temperature, scan speed, and roller 
speed, can signifi cantly affect the quality of sintered objects. 
In order to obtain 3D objects with accurate dimensions as 
designed, good structural and handling stability, and suffi cient 
mechanical properties, SLS parameters need to be studied and 
optimized. For parameter optimization, the one-factor-at-a-time 
method for experimentation, in which one SLS parameter is 
varied at a time with the other parameters being kept constant, 
is usually employed. 21 However, results obtained through this 
method do not provide information about potential interac-
tions among two or more factors, and hence do not refl ect the 
real situation. To be closer to the actual sintering process, the 
factorial design methodology can be employed to evaluate 
the main effects and also interactions of joint factor effects on 
the response variables. Partee et al. used the two-level factorial 
design of experiments (DOE) technique to optimize SLS param-
eters for making poly( ε -caprolactone) (PCL) tissue engineering 
scaffolds. 22 Using the optimized parameters, solid PCL samples 
  
 Figure 2.  Selective laser sintering (SLS) fabrication of Ca-P/PHBV nanocomposite 
scaffolds. (a) Scanning electron microscopic (SEM) image of Ca-P nanoparticles. (b) SEM 
image of Ca-P/PHBV nanocomposite microspheres; (c) Sinterstation 2000 SLS machine. 
(d) Miniature sintering platform installed in the modifi ed Sinterstation 2000 machine. 
(e) A porous scaffold model based on the 3D model of the proximal end of a human femur 
reconstructed from computed tomography images. (f) Sintered Ca-P/PHBV nanocomposite 
scaffold. (Real scaffold size: two-fi fths of the design model.) 
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and porous PCL scaffolds with 1D, 2D, and 3D orthogonal, 
periodic porous architectures were produced via SLS. 23 Simi-
larly, our group considered three important aspects of scaffolds, 
namely structure and handling stability, dimensional accuracy, 
and compressive properties, and used DOE with three factors 
(laser power, scan spacing, and layer thickness) and three levels 
(high, medium, and low values of respective factor) to optimize 
SLS parameters for fabricating Ca-P/PHBV nanocomposite 
scaffolds. 24 With optimized SLS parameters, 3D porous struc-
tures or scaffolds with complex interior and exterior geometries 
could be produced. 25 
 Applications of SLS in biomedical engineering 
 SLS can have many applications in biomedical engineering. An 
overview of the biomedical applications is presented, highlight-
ing the use of SLS for tissue engineering scaffolds and drug/
biomolecule delivery systems. 
 Tissue engineering scaff olds 
 Traditional treatments for diseased or traumatized human body 
tissues involve the use of autograft, allograft, and biomaterials 
(natural or synthetic, including biocompatible polymers, met-
als, ceramics, and composites) for tissue repair. However, there 
are major limitations such as shortage of donor tissue, graft 
rejection, and lack of bioactivity. As a promising new strategy, 
tissue engineering emerged and involves the creation of bio-
logical substitutes that integrate with the host and evolve into 
newly formed tissue at the repair sites. 26 For scaffold-based tissue 
engineering, controlling the macro- and micro-architecture 
of the scaffold and hence fulfi lling a customized design with 
complex anatomic shape is of signifi cant importance for the 
clinical application of the scaffold. 27 In scaffold fabrication, 
in contrast with non-designed manufacturing techniques 
such as solvent casting/porogen leaching, freeze-drying, and 
gas foaming, designed manufacturing techniques such as SLS 
make it possible to achieve extensive and detailed control over 
scaffold architecture. 28 
 Biopolymers (degradable or non-degradable), ceramics, 
and composites can be processed into scaffolds via SLS for 
bone tissue repair or bone tissue engineering. Rimell and 
Marquis used a simplifi ed SLS apparatus to sinter ultrahigh 
molecular weight polyethylene implants. 29 Other powdered 
non-degradable polymers such as polyetheretherketone 
(PEEK) have also been sintered. 30 However, single-component 
biomaterials cannot fully fulfi ll the requirements for bone 
graft substitutes. Therefore, composite scaffolds based on non-
degradable polymers and HA, including HA/PEEK and HA/
high-density polyethylene (HDPE), were made via SLS. 31 , 32 
HA/HDPE scaffolds were intended as customized maxillo-
facial implants. HA in the composite scaffolds enhanced cell 
proliferation, increased alkaline phosphatase activity, and 
produced more osteocalcin (a biochemical marker for new 
bone formation). 33 In the HA/PEEK system, different amounts 
of HA were incorporated, and scaffolds had well-defi ned pore 
interconnectivity. 34 By varying the HA amount, the porosity, 
mechanical properties and bioactivity of HA/PEEK scaffolds 
were controlled. 
 Within the conventional notion of tissue engineering, tis-
sue engineering scaffolds should be biodegradable, and the 
degradation rate should be synchronized with the rate of neo-
tissue formation. Therefore, for tissue engineering scaffold 
fabrication, the majority of research focuses on biodegradable 
polymers or their composites. The most widely used biodegradable 
polymer for scaffolds formed by SLS is probably PCL, due 
to its good biocompatibility and low melting temperature. 35 
Williams et al. pioneered the fabrication of PCL scaffolds via 
SLS. 36 The sintered PCL scaffolds, with an orthogonal intercon-
nected pore design, were seeded with human gingival fi broblas-
tic cells and subcutaneously implanted in immunocompromised 
mice. Micro-CT data and histological images showed that bone 
formed on scaffolds or inside the pores of scaffolds. Ciardelli 
et al. used SLS to sinter blended microparticles of PCL and a 
polysaccharide (starch, dextran, or gelatin) and systematically 
studied the morphology, thermal behavior, and cell compatibil-
ity of the composite scaffolds formed. 37 Other biodegradable 
polymers, such as poly(vinyl alcohol) (PVA), poly(L-lactic 
acid) (PLLA), and PLGA, were also successfully processed 
into scaffolds via SLS. 38 , 39 Bioceramics such as HA can be 
incorporated into biodegradable polymers to form composite 
bone tissue engineering scaffolds. Blends of PCL and HA were 
used to fabricate tissue engineering scaffolds via SLS. 21 Good 
sintering results were achieved for these HA/PCL compos-
ite scaffolds by optimizing SLS parameters, and the scaffolds 
exhibited both  in vitro bioactivity and  in vitro cell compatibility. 
Other composite scaffolds such as HA/PVA and HA/PLGA 
have also been made via SLS. 39 , 40 
 The paradigm has shifted from conventional fabrication 
technologies to microtechnology and now toward nanotechnol-
ogy for improving the mechanical and biological properties of 
biomaterials. For example, nanostructured Ca-P and nanocom-
posites incorporating nano-sized Ca-P provided better osseoin-
tegration as compared to their larger particle size counterparts 
owing to their bioresorbability and high surface area. 41 , 42 For 
Ca-P/PHBV and Ca-P/PLLA nanocomposite scaffolds, in order 
to homogeneously incorporate Ca-P nanoparticles, nanocompos-
ite microspheres consisting of nano-sized Ca-P and a PHBV 
or PLLA matrix were fabricated fi rst. 43 The nanocomposite 
microspheres then served as raw materials for SLS in the 
fabrication of nanocomposite scaffolds. 43 , 44 
 Apart from bone tissue engineering scaffolds, SLS can also 
be used to fabricate scaffolds for the repair or regeneration of 
other tissues. Liu et al. blended epoxy resin E-12 (as a binder) 
with K 2 O-Al 2 O 3 -SiO 2 series dental glass-ceramic, forming fi ne 
powder composites, and then manufactured dental restoration 
devices using SLS. 45 PCL scaffolds with tailored architecture 
and mechanical properties were fabricated via SLS to accom-
modate C2C12 myoblast cells for cardiac tissue engineering. 46 
To engineer implantable liver tissues, Huang et al. designed a 
PCL scaffold with a 3D branching and joining fl ow-channel 
network and fabricated the scaffold using SLS. 47 
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 Drug/biomolecule delivery vehicles 
 SLS can also be used to fabricate 3D devices for drug or 
biomolecule incorporation and delivery. Leong et al. dem-
onstrated the fabrication of drug delivery devices (DDDs, in 
the form of cylinders 9 mm long) by selective laser sintering 
nylon powders and used methylene blue dye as the model 
drug. 48 In order to control the release profi le, two features, 
namely porous microstructure and dense wall formation, 
were investigated for their roles in storing drugs and con-
trolling the release of drugs through the diffusion process. 49 
 In vitro release tests indicated that SLS-formed devices were 
capable of retarding the release of model drugs into a simu-
lated environment. Although non-degradable reservoir-type 
DDDs can provide zero-order release with the diffusion of 
drugs through the shell, they are hardly used in regenerative 
medicine. By using biodegradable polymers, however, DDDs 
made by SLS can be used for controlled drug/biomolecule 
release. PCL with methylene blue was sintered into a DDD. 50 
The drug release profi le could be modifi ed by the addition 
of a barrier layer to the DDD, which acted to reduce the 
initial burst. 
 Generally, drugs are loaded either by blending with poly-
mer powders before SLS (Method A) or by adsorption on 
DDD after SLS (Method C), as illustrated in  Figure 3 . For 
example, a PCL-progesterone (PG, a steroid hormone) drug 
delivery system was fabricated by sintering PCL and PG pow-
der mixtures. 51 Alternatively, drugs or biomolecules can be 
encapsulated in microspheres and the microspheres subse-
quently used for SLS (Method B,  Figure 3 ). As a demonstra-
tion, our group encapsulated bovine serum albumin (BSA) 
in Ca-P/PHBV nanocomposite microspheres. 52 The BSA-
loaded Ca-P/PHBV microspheres were then processed into 
3D scaffolds with good dimensional accuracy via SLS. The 
nanocomposite microspheres served as protective carriers for 
BSA during SLS. In the  in vitro release study, an initial BSA 
burst release was observed from surface molecules, which 
was followed by a slow release from the encapsulated BSA. 52 
The BSA encapsulation effi ciency was found to be relatively 
low due to the incorporation method, materials used, and 
SLS process. 
 Conventional SLS can be used for incorporating drugs, 
which are not heat-sensitive, and SSLS offers a better choice 
for incorporating heat-sensitive drugs or biomolecules. Scaf-
folds composed of poly(D,L-lactic acid) (PDLLA) and a protein 
were made via SSLS. 53 The protein in the scaffolds sintered at 
various laser intensities retained substantial activity after SSLS. 
 In tissue engineering, scaffolds alone may not cause sponta-
neous healing and regeneration of functional tissue due to the 
lack of biochemical inducements such as growth factors, which 
promote cell proliferation and differentiation. Although biomol-
ecules could be incorporated in 3D scaffolds by sintering mixed 
powders of biomolecules and polymer granules or by sintering 
biomolecule-loaded microspheres, SLS may cause severe dam-
age to biomolecules due to the heat generated. One approach 
to avoid this problem is to bind biomolecules to scaffolds after 
their fabrication by SLS. In our study, in order to better control 
the growth factor release behavior, surface modifi cation of 
sintered Ca-P/PHBV scaffolds was fi rst conducted through 
physical entrapment of gelatin and subsequent immobilization 
of heparin. 25 Recombinant human bone morphogenetic protein 
(rhBMP)-2 was then loaded on the surface modifi ed scaffolds 
(Method D in  Figure 3 ). The rhBMP-2 could be released in a 
controlled and sustained manner due to the specifi c affi nity 
between heparin and rhBMP-2. This strategy not only provided 
a means to protect the loaded rhBMP-2 but also improved the 
rhBMP-2 release behavior. 
 In the subsequent  in vitro study, the pluripotent mesenchy-
mal stem cell line C3H10T1⁄2 was seeded on bare Ca-P/PHBV 
scaffolds and surface modifi ed Ca-P/PHBV scaffolds loaded 
with rhBMP-2. Proliferating cells were observed to cover all 
surfaces of surface modifi ed and rhBMP-2 loaded scaffolds 
( Figure 4 a). At a higher magnifi cation, the formation of a Ca-P 
(or apatite) layer on some Ca-P-PHBV microspheres of the 
scaffold strut surface was also observed ( Figure 4b ), and there 
appeared to be interactions between cells and the Ca-P covered 
microspheres. In  in vivo experiments, Ca-P/PHBV scaffolds 
with or without rhBMP-2 were implanted in a drilled hole in 
the ilium of New Zealand white rabbits. Six weeks after implan-
tation, micro-CT data showed that there was very limited bone 
formation in Ca-P/PHBV scaffolds without rhBMP-2 loading 
( Figure 5 a), with the defect (the drilled hole) 
being occupied by the scaffold. In contrast, new 
bone was formed adjacent to and inside the sur-
face modifi ed and rhBMP-2 loaded scaffold 
( Figure 5b ). Histological examination showed 
that with surface modifi ed and rhBMP-2 loaded 
scaffold, the center of the defect (the drilled 
hole) was filled with newly formed bone 
( Figure 6 c), whereas there was no bone for-
mation in the center of the defect treated with 
a scaffold without rhBMP-2, and new bone for-
mation was stimulated only at the periphery of 
the defect ( Figure 6a ). Bone remodeling, or the 
replacement of old bone with new, which exhib-
ited the light pink color in  Figure 6d , was also 
  
 Figure 3.  Four strategies for developing drug delivery systems using selective laser 
sintering. DDD, drug delivery device; SLS, selective laser sintering. 
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observed in the group treated with surface modifi ed and rhBMP-2 
loaded scaffolds. These investigations have demonstrated that the 
surface modifi cation can provide binding sites for growth factors 
and control their sustained release  in vitro and  in vivo. 
 Biomedical prototypes and devices 
 When it was fi rst borrowed from the manufacturing industry for 
biomedical applications, SLS was used to produce accurate 
models of elements such as the skull, mandible, and neuro-
network for simulation and surgical planning, particularly in 
the craniofacial and maxillofacial fi elds and for neurosurgery. A 
few engineering materials in powdered form, such as polycar-
bonate, nylon (standard nylon, fi ne nylon, fi ne nylon medical 
grade, and nylon composite) and acrylic, can be used to cre-
ate these models. Using high-resolution, multiplanar imaging 
techniques such as MRI and CT, 3D medical image data can be 
obtained and used to reconstruct 3D models, which are utilized 
for fabrication via SLS. Physical models of the brain and skull 
were thus made using SLS for training in procedures of deep 
microvascular anastomosis. 54 Using the fabricated model, neu-
rosurgeons could practice with both realistic depth and width 
when manipulating operative instruments. The accuracy of 
biomedical prototypes is very important for surgical planning. 
The shape, dimensions, and anatomic details of prototypes may 
be affected by errors at any phase of the SLS process. Silva et 
al. analyzed the capability of SLS to reproduce craniomaxil-
lary anatomy and compared the accuracy of an anatomical 
model made by SLS with that of a model fabricated by 3DP. 55 
The SLS prototypes showed greater dimensional precision and 
reproduced craniomaxillary anatomy more accurately than the 
3DP models. SLS prototypes also had a greater dimensional 
accuracy in reproducing mandibular anatomy than models pro-
duced by 3DP using a PolyJet machine. 56 
 One distinctive advantage of RP techniques for biomedical 
engineering is the fabrication of customized medical devices, 
catering to the needs of individual patients. Using SLS, Wu 
et al. fabricated a wax pattern of a partial nasal prosthesis. 57 
Montgomery et al. designed an actively actuated prosthetic 
socket (the portion of the prosthesis that attaches to the residual 
  
 Figure 4.  C3H10T1/2 cells cultured on a surface-modifi ed 
and rhBMP-2 loaded Ca-P/PHBV nanocomposite scaffold for 
21 days. (a) General view of cells on the scaffold. (b) A high 
magnifi cation view. Solid white arrows indicate cell-covered 
Ca-P/PHBV microspheres; the hollow white arrow indicates a cell. 
  
 Figure 5.  Micro-CT reconstructed images of scaffolds 
implanted in the ilium of rabbits for six weeks. (a) Ca-P/PHBV 
scaffold. (b) Surface-modifi ed and rhBMP-2-loaded Ca-P/PHBV 
scaffold. HB, host bone. White arrows are pointing at newly 
formed bone within the scaffold in a drilled hole (defect). 
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limb of an amputee and serves a variety of functions) and 
using nylon, manufactured the adaptive socket according to 
the design. 58 Test results indicated great potential of the socket 
that could provide greater comfort and fi t to avoid movement 
problems and rehabilitation diffi culties. Another example of 
SLS applications is orthotic device fabrication. Using SLS, 
Faustini et al. manufactured ankle-foot orthoses (AFOs), which 
are assistive or therapeutic devices to improve the gait perfor-
mance of people with impaired lower limb function. 59 SLS 
allowed the fabrication of AFOs directly from digital shape 
information of a patient’s limb and enabled the optimization of 
characteristics, such as weight, stiffness and shape, of AFOs. 
Customized foot orthoses, which lessen the symptoms of 
rheumatoid arthritis and improve function and mobility, have 
also been fabricated using SLS. 60 
 Summary and outlook 
 SLS is a versatile RP technique that has exhibited great potential 
for biomedical applications. With careful modifi cations, com-
mercial SLS machines can use small amounts of powdered 
materials to produce designed objects for specifi c biomedical 
applications. It has been shown by different research groups 
that optimization of SLS parameters is of great importance for 
fabricating designed objects with good quality and high accu-
racy. Using data obtained from medical imaging techniques 
such as MRI and CT, anatomically shaped tissue engineering 
scaffolds with specifi cally designed architectures, customized 
medical devices, and surgical models can be produced via SLS. 
Drug/biomolecule delivery systems can also be 
fabricated either by sintering drug and polymer 
blends or drug/biomolecule-containing micro-
spheres or by adsorption of drug or noncovalent 
binding of biomolecules to SLS-formed delivery 
vehicles. 
 For tissue engineering, the control over 
mechanical properties and degradation behav-
ior of sintered scaffolds is important. These 
properties are affected by the biodegradable 
materials used, scaffold design, and optimiza-
tion of SLS parameters. One disadvantage of 
the SLS technique for scaffold fabrication is 
that hydrogels cannot be used, and it is also 
impossible to encapsulate cells in scaffolds. 
Using appropriate cell seeding techniques and 
advanced bioreactors should ensure that cells 
are homogeneously distributed on 3D scaffolds 
and also in pores inside the scaffolds. 
 The incorporation and release of chemo-
tactic cues (e.g., growth factors) can facilitate 
the cell homing process. Our surface modifi ed 
nanocomposite scaffolds with immobilized 
heparin can be loaded with two different growth 
factors, such as bone morphogenetic proteins, 
vascular endothelial growth factors, and fi bro-
blast growth factors. The growth factors are 
expected to be released independently in a controlled and 
sustained manner independently and to stimulate the tissue 
regeneration in an orchestrated way. The lack of vasculariza-
tion within the scaffold is still a major issue for 3D scaffolds 
targeted at specifi c tissue regeneration. The dual growth factor 
delivery approach can overcome this by stimulating angiogene-
sis, nourishing the newly formed tissue, and improving  in vivo 
integration with host tissue. Apart from loading two different 
growth factors on scaffolds, the dual release approach can be 
employed to encapsulate drugs in scaffolds in combination with 
loading growth factors on the surface. Some small-molecule 
drugs such as antibiotics and anti-infl ammation drugs can be 
incorporated in SLS-formed scaffolds, as they may be able to 
withstand the SLS process. A local delivery system providing a 
sustained release of suffi cient doses of antibiotics after surgery 
has clinical benefi ts in preventing infections during the treat-
ment of bone defects or bone fractures. 
 SLS is capable of fabricating objects with gradient struc-
tures. 61 – 63 Sintered functionally graded scaffolds could have 
potential applications in interface tissue engineering (e.g., 
osteochondral tissue engineering). With gradual changes in 
composition and structure, functionally graded scaffolds can 
mimic bone and cartilage properties and form the osteochon-
dral interface. Currently, SLS can create multilayer function-
ally graded objects in which the material gradient is oriented 
along the build direction. Advanced SLS machines should be 
developed to automatically load different materials or materials 
of different compositions according to scaffold designs. With 
  
 Figure 6.  Histological images of tissues after scaffold implantation in the ilium of rabbits 
for six weeks: (a, b) Ca-P/PHBV nanocomposite scaffold; (c, d) surface-modifi ed and 
rhBMP-2-loaded Ca-P/PHBV scaffold. S, scaffold; HB, host bone; NB, new bone. (a, c) 
General view; (b, d) close view. 
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further development of SLS technology, the fabrication and 
use of complex scaffolds with gradient composition and/
or structure in three directions will greatly advance tissue 
engineering. 
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